The Cost of Integrated HIV Care and Buprenorphine/ Naloxone Treatment: Results of a Cross-Site Evaluation

BACKGROUND: Implementing integrated HIV and buprenorphine/ naloxone treatment requires cost estimates to plan and obtain funding. METHODS: We identified costs incurred at HIV clinical sites participating in a cross-site evaluation of integrated care that followed patients for 1 year. Costs include l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Schackman, Bruce R., Leff, Jared A., Botsko, Michael, Fiellin, David A., Altice, Fredrick L., Korthuis, P. Todd, Sohler, Nancy, Weiss, Linda, Egan, James E., Netherland, Julie, Gass, Jonathan, Finkelstein, Ruth
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3270565/
https://ncbi.nlm.nih.gov/pubmed/21317599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31820a9a66
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak